Pr François Kleinclauss

Diplôme interuniversitaire de Chirurgie Robotique - Université Henri Poincaré, Nancy

Post doc, Division of Transplantation, Dept of Surgery - University of Minnesota, USA

Doctorat de l’Université de Franche Comté, Spécialité : Homme, Environnement, Santé - Université de Franche-Comté, Besançon

Diplôme d’Habilitation à diriger les Recherches (HDR) - Université de Franche-Comté, Besançon

Diplôme Inter-universitaire (DIU) de Pédagogie Médicale - Université Henri Poincaré, Nancy

Diplôme Inter-universitaire (DIU) de Chirurgie Laparoscopique Urologique - Université Louis Pasteur, Strasbourg

Diplôme d’Etudes Spécialisées Complémentaire (DESC) d’Andrologie - Université de Franche-Comté, Besançon

Diplôme d’Etudes Spécialisées Complémentaire (DESC) d’Urologie - Université de Franche-Comté, Besançon

Diplôme d'État de docteur en médecine - Université de Franche-Comté, Besançon

Chef de service - Centre Hospitalier Régional Universitaire de Besançon - Besançon - Service d’Urologie, Andrologie et Transplantation rénale

Cabinet - Besançon

Professeur des universités-praticien hospitalier - Centre Hospitalier Régional Universitaire de Besançon - Besançon - Service d’Urologie, Andrologie et Transplantation rénale

Maitre de Conférence, Praticien Hospitalier - Centre Hospitalier Régional Universitaire de Besançon - Besançon - Service d’Urologie, Andrologie et Transplantation rénale

Chef de clinique - Centre Hospitalier Régional Universitaire de Besançon - Besançon - Service d’Urologie, Andrologie et Transplantation rénale

Interne - Centre Hospitalier Régional Universitaire de Besançon - Besançon - Service d’Urologie, Andrologie et Transplantation rénale

Membre du comité scientifique - Association Française d’Urologie (AFU)

Responsable du Comité Insuffisance rénale et Transplantation - Association Française d’Urologie (AFU)

ESTU board member - European Association of Urology (EAU)

Énucléation versus orchidectomie totale dans la prise en charge des tumeurs testiculaires à cellules de Leydig : résultats d'une étude multicentrique rétrospective.

Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features.

Impact of obesity on pathologic outcomes and biochemical reccurence after radical prostatectomy.

Urological complications of renal transplantation.

Néphrectomie partielle du transplant rénal : étude multicentrique.

Nephron sparing surgery for De Novo kidney graft tumor: results from a multicenter national study.

Neoadjuvant before surgery treatments: state of the art in prostate cancer.

Meteo-U-rology: climate impact on urological emergencies

Ischemia-reperfusion in the renal allograft: new clues in a cold-case.

Flexible ureterorenoscopy in obese patients: results from a large monocenter cohort.

Existence of pattern 5 on radical prostatectomy: poor prognostic factor associated with a lower biochemical recurrence-free survival.

Evaluation of the activity of a urological emergency unit in university hospital.

Comparison of the efficacy and morbidity of flexible ureterorenoscopy for lower pole stones compared with other renal locations.

Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study.

Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma.

Treatment of bladder outlet obstruction in locally advanced prostate cancer.

Safety and efficacy of cabazitaxel in the docetaxel-treated patients with hormone-refractory prostate cancer.

Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control study.

Urinary complications of one-stitch ureteroneocystostomy in renal transplantation.

Ureterorenoscopy with holmium-yttrium-aluminum-garnet fragmentation is a safe and efficient technique for stone treatment in patients with a body mass index superior to 30 kg/m2.

Risk factors for surgical complications after renal transplantation and impact on patient and graft survival.

Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?

Pituitary function and glucose tolerance in a family with a PAX6 mutation.

Outcomes of renal transplantation in obese recipients.

Muscularis mucosae invasion: prognostic factor for intravesical BCG immunotherapy failure for T1 bladder carcinoma.

Metabolic impact of androgen deprivation therapy for prostate cancer.

Loss of central and peripheral CD8+ T-cell tolerance to HFE in mouse models of human familial hemochromatosis.

Kidney transplantation in obese recipients: review of the Transplantation Committee of the French Association of Urology.

Is SIGAPS score a good evaluation criteria for university departments?

Intravenous infusion of donor apoptotic leukocytes before transplantation delays allogeneic islet graft rejection through regulatory T cells.

Immunotherapy: an emerging strategies against prostate castration resistant cancer.

Folliculosebaceous cystic hamartoma: anatomo-clinical study.

De novo kidney graft tumors: results from a multicentric retrospective national study.

Accuracy of prostate biopsies to evaluate tumor location in prostate cancer.

Wegener's granulomatosis: a rare cause of hydronephrosis.

Surgical management of BPH in patients on oral anticoagulation: transurethral bipolar plasma vaporization in saline versus transurethral monopolar resection of the prostate.

Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.

Immunosuppression in kidney transplantation.